1-10 of 10
Francesca Russo
Close
Sort by
Journal Articles

Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis

Clinical Trials & Observations
Efstathios Kastritis, Ioannis Papassotiriou, Giampaolo Merlini, Paolo Milani, Evangelos Terpos, Marco Basset, Athanasios Akalestos, Francesca Russo, Erasmia Psimenou, Filia Apostolakou, Maria Roussou, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Dimitrios C. Ziogas, Elektra Papadopoulou, Constantinos Pamboucas, Meletios A. Dimopoulos, Giovanni Palladini
Journal: Blood
Blood (2018) 131 (14): 1568–1575.
https://doi.org/10.1182/blood-2017-12-819904
Published: 2018
Includes: Supplemental data
Journal Articles

Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies

Clinical Trials & Observations
Giovanni Palladini, Paolo Milani, Andrea Foli, Marco Basset, Francesca Russo, Stefano Perlini, Giampaolo Merlini
Journal: Blood
Blood (2018) 131 (5): 525–532.
https://doi.org/10.1182/blood-2017-04-780544
Published: 2018
Includes: Supplemental data
Journal Articles

Liver Involvement and d FLC Level Affect Survival of Patients with Non-Cardiac Light Chain Amyloidosis: A European Study of 334 Patients

Giovanni Palladini, MDPhD, Ute Hegenbart, Paolo Milani, MD, Marco Basset, MD, Christoph Kimmich, MD, Francesca Russo, MD, Tilman Bochtler, MD, Andrea Foli, MD, Giampaolo Merlini, MD, Stefan Schönland, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1759.
https://doi.org/10.1182/blood.V130.Suppl_1.1759.1759
Published: 2017
Journal Articles

Biomarker-Based Screening of Organ Dysfunction in Patients with MGUS Allows Early Diagnosis of AL Amyloidosis

Giovanni Palladini, MDPhD, Marco Basset, MD, Paolo Milani, MD, Marzia Varettoni, MD, Silvia Mangiacavalli, MD, Francesca Russo, MD, Andrea Foli, MD, Alessandro Corso, MD, Giampaolo Merlini, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1760.
https://doi.org/10.1182/blood.V130.Suppl_1.1760.1760
Published: 2017
Journal Articles

Persisting Cardiac Dysfunction and Quality of Response Predict Survival in Patients with AL Amyloidosis Who Respond to Upfront Therapy

Giovanni Palladini, MDPhD, Paolo Milani, MD, Marco Basset, MD, Francesca Russo, MD, Andrea Foli, MD, Giampaolo Merlini, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4346.
https://doi.org/10.1182/blood.V130.Suppl_1.4346.4346
Published: 2017
Journal Articles

Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome

Paolo Milani, Marco Basset, Francesca Russo, Andrea Foli, Giampaolo Merlini, Giovanni Palladini
Journal: Blood
Blood (2017) 130 (5): 625–631.
https://doi.org/10.1182/blood-2017-02-767467
Published: 2017
Includes: Supplemental data
Journal Articles

A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis

Clinical Trials & Observations Brief Report
Giovanni Palladini, Paolo Milani, Andrea Foli, Marco Basset, Francesca Russo, Stefano Perlini, Giampaolo Merlini
Journal: Blood
Blood (2017) 129 (15): 2120–2123.
https://doi.org/10.1182/blood-2016-12-756528
Published: 2017
Includes: Supplemental data
Journal Articles

Persistence of Minimal Residual Disease By Multiparameter Flow Cytometry Can Hinder Recovery of Organ Damage in Patients with AL Amyloidosis Otherwise in Complete Response

Giovanni Palladini, MD PhD, Margherita Massa, Marco Basset, MD, Francesca Russo, MD, Paolo Milani, MD, Andrea Foli, MD, Giampaolo Merlini, MD
Journal: Blood
Blood (2016) 128 (22): 3261.
https://doi.org/10.1182/blood.V128.22.3261.3261
Published: 2016
Journal Articles

Patterns of Relapse after Upfront Therapy in AL Amyloidosis

Paolo Milani, MD, Marco Basset, MD, Francesca Russo, MD, Andrea Foli, MD, Giovanni Palladini, MD PhD, Giampaolo Merlini, MD
Journal: Blood
Blood (2016) 128 (22): 2140.
https://doi.org/10.1182/blood.V128.22.2140.2140
Published: 2016
Journal Articles

Growth Differentiation Factor-15 (GDF-15) Is a New Biomarker with Independent Prognostic Significance for Survival and Renal Outcomes in Different Cohorts of Patients with Light Chain (AL) Amyloidosis

Efstathios Kastritis, MD, Giampaolo Merlini, MD, Ioannis Papassotiriou, PhD, Paolo Milani, MD, Evangelos Terpos, Marco Basset, MD, Athanasios Akalestos, Francesca Russo, Erasmia Psimenou, Filia Apostoloakou, Maria Roussou, Maria Gavriatopoulou, Despina Fotiou, Dimitrios Ziogas, Constantinos Pamboucas, Elektra Papadopoulou, Meletios A Dimopoulos, Giovanni Palladini, MD PhD
Journal: Blood
Blood (2016) 128 (22): 648.
https://doi.org/10.1182/blood.V128.22.648.648
Published: 2016